RR
Ravi Ranjan Kumar
About Ravi Ranjan Kumar
Data last updated:
Ravi Ranjan Kumar is a Director at Nettle Pharmaceuticals Private Limited (since 2018). The companies operate in Pharma. Nettle Pharmaceuticals Private Limited reported revenue of ₹30,025 (FY 2024). Earlier, Ravi Ranjan Kumar was a Director at Reddwings Production Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nettle Pharmaceuticals Private Limited U33110DL2012PTC243599 | Director | 27 Apr 2018 | 2012 | ₹30,025 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Reddwings Production Private Limited U92490DL2019PTC353869 | Director | 14 Aug 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravi Ranjan Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohammad Murtuja | 08008082 | Nettle Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Ranjan Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Ranjan Kumar
Ravi Ranjan Kumar currently holds 1 directorship: Nettle Pharmaceuticals Private Limited (Director, since 27 Apr 2018, revenue ₹30,025 (FY 2024)).
Ravi Ranjan Kumar was first appointed on 27 Apr 2018 as Director at Nettle Pharmaceuticals Private Limited. The most recent appointment on record is 14 Aug 2019 at Reddwings Production Private Limited.
Ravi Ranjan Kumar held 1 earlier board appointment: Reddwings Production Private Limited (Director, from 14 Aug 2019).
The current boards of Ravi Ranjan Kumar's companies include Mohammad Murtuja (Nettle Pharmaceuticals Private Limited).